-
Hiding in plain sight: Improved CAR T-cell therapy for T-cell acute lymphoblastic leukemia
08/05/2022
St. Jude scientists developed a simple method to select for more effective cancer-destroying CAR T cells to treat T-ALL.
-
Getting more mileage from a T-cell therapy for AML
07/28/2022
St. Jude scientists have created a proof-of-principle approach to improve engager T-cell therapy for difficult-to-treat acute myeloid leukemia.
-
Frank Fazio named president of Children's GMP and vice president of therapeutics production and quality at St. Jude
07/27/2022
The Good Manufacturing Practices (GMP) facility produces highly specialized biopharmaceuticals and other biological products for the hospital’s clinics.
-
Genetics weigh heavy on childhood cancer survivors’ risk of developing obesity
07/25/2022
St. Jude scientists created a way to identify childhood cancer patients at diagnosis who are at the highest risk for developing severe obesity as adults.
-
Study reveals a new therapeutic target for aggressive type of rhabdomyosarcoma
07/13/2022
Scientists at St. Jude found an Achilles’ heel in rhabdomyosarcoma driven by a gene fusion which revealed a promising treatment approach in the lab.
-
St. Jude Children’s Research Hospital announces expansion of its strategic plan to target pediatric catastrophic diseases
07/13/2022
Six-year plan will now commit $12.9 billion to support 2,300 jobs, among other priorities.
-
STEMM immersion program to shape the next generation of scientists
07/11/2022
St. Jude High School and College Research Immersion Program introduces science to a diverse group of students
-
Primary cilia in medulloblastoma: mechanisms provide treatment opportunity
07/07/2022
St. Jude scientists have shown how the presence or absence of primary cilia contribute to specific types of the most common malignant childhood brain tumor.
-
Researchers create a single-cell framework to potentially enhance CAR T–cell therapy
07/06/2022
St. Jude scientists developed a method that could improve CAR T-cell therapies by identifying the early cells that become effective at killing cancer.
-
Arkansas State Rep. Dwight Tosh honored at St. Jude for 60-year survival of childhood cancer
06/24/2022
Tosh is the first St. Jude patient to reach this milestone and was recognized at institution’s 60th anniversary celebration
Explore more research news
More Research News
-
Scientific Report 2021
The Scientific Report, Translating Science into Survival, describes key breakthroughs made by St. Jude investigators.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.